OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push 
Elliott Investment Takes ~3% Stake in Daikin, Pushes for Buybacks and Strategic Overhaul 
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch 
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle 
NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers 
Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent 
TSMC Posts Record Q1 Profit Fueled by AI Chip Demand 
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push 
Pentagon Taps Auto Giants to Supercharge U.S. Weapons Production 
Samsung Races to Deliver Next-Gen HBM4E Memory Samples to Nvidia 
Iran War Drives Asia's Plastic Crisis — and a Green Packaging Boom 
Hermès Q1 2026 Sales Miss Expectations Amid Iran War and China Slowdown 
Want to cut your energy bills? Here’s how five experts are doing it 
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits 
Daikin Industries Stock Surges 14% After Elliott Investment Management Discloses Major Stake 
Japan Opens Arms Export Floodgates: New Policy Draws Global Defense Interest 
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million 
SOMERSET, N.J., March 31, 2016 -- MTBC (NASDAQ:MTBC), a leading provider of proprietary, healthcare information technology solutions today announced it’s providing its leading e-prescribing solution free of charge for a limited period of time to physicians who have yet to implement an e-prescribing solution in the wake of New York’s new e-prescribing mandate.
“As of this week, New York’s I-STOP law took effect for all New York physicians and pharmacists,” said Amritpal Deol, MTBC General Counsel. She added, “I-STOP, which marks the beginning of a national trend, requires that all prescriptions be issued electronically, thereby rendering the paper prescription pad a relic of a bygone era.”
As part of MTBC’s I-STOP promotion, New York physicians who signup for MTBC’s e-prescribing by May 1, 2016, are entitled to use MTBC eRx free of charge for one year. This promotional offer is limited to 5 physicians per practice and only available to the first 500 physicians who contact MTBC.
MTBC eRx, MTBC’s proprietary electronic prescribing solution, is fully integrated with PracticeProTM, which includes a certified web-based EHR, practice management and revenue cycle management system. MTBC’s proprietary e-prescribing solution is available as an app, MTBC iRx, for Apple and Android users and an app for Apple Watch.
All of MTBC e-prescribe solutions are Surescripts® White Coat certified and facilitate controlled substances electronic prescribing through integration with EPCS Gold 2.0 by DrFirst®.
To learn more about MTBC, please visit www.mtbc.com.
About Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp. is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC's common stock trades on the NASDAQ Capital Market under the ticker symbol "MTBC," and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol "MTBCP."
For additional information, please visit our website at www.mtbc.com.
Press Contact: Amritpal Deol, Vice President and General Counsel MTBC [email protected] (732) 873-5133 x 141
